VYERA PHARMACEUTICALS
Live / Registered — Registered (as of 19 Oct 2021)
What this means for you
Registered since 19 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87673086
- Registration number
- 6531043
- Mark type
- Stylized text
- Filed
- 06 Nov 2017
- Published for opposition
- 17 Apr 2018
- Registered
- 19 Oct 2021
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of toxoplasmosis
Owner
- PHOENIXUS AG, Baar, CH
- PHOENIXUS AG, Baar, CH
- VYERA PHARMACEUTICALS AG, New York, NY, CH
- VYERA PHARMACEUTICALS AG, New York, NY, CH
- Turing Pharmaceuticals AG, New York, NY, CH
Prosecution history
- 19 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Aug 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 03 May 2021 — USE AMENDMENT FILED
- 11 Jun 2021 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 11 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 May 2021 — ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
- 03 May 2021 — TEAS STATEMENT OF USE RECEIVED
- 23 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Dec 2020 — SOU EXTENSION 5 GRANTED
- 03 Dec 2020 — SOU EXTENSION 5 FILED
- 21 Dec 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Dec 2020 — SOU TEAS EXTENSION RECEIVED
- 18 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED